SEARCH

SEARCH BY CITATION

REFERENCES

  • AlwanS,ReefhuisJ,RasmussenS, et al.2005.Maternal use of selective serotonin re-uptake inhibitors and risk for birth defects (Abstract).Birth Defects Res A Clin Mol Teratol 73:291.
  • CedergrenMI,KällénBAJ.2003.Maternal obesity and infant heart defects.Obesity Res 11:10651071.
  • Diav-CitrinO,SchechtmanS,WeinbaumD, et al.2005.Paroxetine and fluoxetine in pregnancy: a multicenter, prospective, controlled study (Abstract).Reprod Toxicol 20:459.
  • EricsonA,KällénB,WiholmB-E.1999.Delivery outcome after the use of antidepressants in early pregnancy.Europ J Clin Pharmacol 55:503508.
  • GhaziHA,SpielbergerC,KällénB.1991.Delivery outcome after infertility —a registry study.Fertil Steril 55:726732.
  • GoldsteinDJ,CorbinLA,SundellKL.1997.Effects of first-trimester fluoxetine exposure on the newborn.Obstet Gynecol 89:713718.
  • HallbergP,SjöblomV.2005.The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects.J Clin Psychopharm 25:5973.
  • HedegaardP,HenriksenTB,SecherNJ, et al.1996.Do stressful life events affect duration of gestation and risk of preterm delivery?Epidemiology 7:339345.
  • HinesRN,AdamsJ,BuckGM, et al.2004.NTP-CERHR Expert Panel report on reproductive and developmental toxicity of fluoxetine.Birth Defects Res B Dev Reprod Toxicol 71:193280.
  • KällénB,Otterblad OlaussonP.2001.Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias?Int J Risk Safety Med 14:115119.
  • KällénB,Otterblad OlaussonP.2003.Maternal drug use in early pregnancy and infant congenital heart defect.Reprod Toxicol 17:255261.
  • KällénB,Otterblad OlaussonP.2006.Antidepressant drugs during pregnancy and infant congenital heart defect. Letter to the Editor.Reprod Toxicol 21:221222.
  • KällénB,Robert-GnansiaE.2005.Maternal drug use, fertility problems, and infant craniostenosis.Cleft Palate Craniofac J 42:589593.
  • KällénK.2002.Maternal smoking and congenital malformations.Fetal Maternal Med Rev 13:6386.
  • OberlanderTF,WarburtonW,MisriS, et al.2006.Neonatal outcome after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.Arch Gen Psychiatry 63:898906.
  • WilliamsM,WooltortonE.2005.Paroxetine (Paxil) and congenital malformations.Canad Med Assoc J 173:13201321.
  • WogeliusP,NørgaardM,MunkEM, et al.2005.Maternal use of selective serotonin reuptake inhibitors and risk of adverse pregnancy outcome (Abstract).Pharmacoepidem Drug Safety 14:S72S73.